These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 520407)

  • 1. Cytotoxicity of human mononuclear cells against chicken and human red blood cells, induced by treatment of the effector cells with phospholipase C.
    Northoff H; Resch K
    Eur J Immunol; 1979 Oct; 9(10):757-61. PubMed ID: 520407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
    Nelson DL; Poplack DG; Holiman BJ; Henkart PA
    Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of alloantibody-sensitized human erythrocytes by peripheral blood mononuclear cells: heterogeneity of effector populations.
    Kimber I; Moore M
    J Clin Lab Immunol; 1981 Jan; 5(1):41-6. PubMed ID: 6260947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC).
    Sato N; Yabuki Y; Toh K; Ishii Y; Kikuchi K
    Immunology; 1979 Mar; 36(3):421-6. PubMed ID: 437836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent, cell-mediated cytotoxicity against human red blood cells: correlation of effector cell type with enzymatic alteration of the target cell surface.
    Yust I; Frisch B; Goldsher N
    Eur J Immunol; 1980 Feb; 10(2):127-31. PubMed ID: 6768574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of interferon on ADCC (I).
    Spangsbjerg N; Heron I
    Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):315-21. PubMed ID: 6659937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
    Rüegg SJ; Jungi TW
    Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.
    Fauci AS; Balow JE; Pratt KR
    J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
    Brier AM; Chess L; Schlossman SF
    J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolysis due to human antibody-dependent cell-mediated cytotoxicity. Lysis of erythrocytes treated with anti-D serum.
    Yust I; Goldsher N; Greenfeld R; Rabinovitz M
    Isr J Med Sci; 1980 Mar; 16(3):174-80. PubMed ID: 6771228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.
    Fuson EW; Shaw MW; Hubbard RA; Lamon EW
    Clin Exp Immunol; 1979 Oct; 38(1):158-65. PubMed ID: 316751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
    Hall RE; Muchmore AV; Blaese RM
    J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    Melewicz FM; Shore SL; Ades EW; Phillips DJ
    J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.
    Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L
    Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous, augmentable cell-mediated cytotoxicity with limited target cell specificity in human blood.
    Saksela E; Imir T; Mäkelä O
    Eur J Immunol; 1977 Mar; 7(3):126-30. PubMed ID: 67951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.